- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06538025
Correlation Between Family Functioning and PSF
October 23, 2024 updated by: Meichun Shu
Post-stroke Fatigue and Its Correlation With Family Functioning in Patients With First-episode Stroke
In the present study, the investigators investigate the effect of family functioning on PSF in neurologic stroke patients in the early stages of the disease by surveying the current status of post-stroke fatigue to provide theoretical support for clinical care.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
212
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Wenzhou, Zhejiang, China, 325000
- Meichun Shu
-
Wenzhou, Zhejiang, China, 325000
- Xianchai Hong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with first-episode stroke admitted to the Department of Neurology of our hospital between October 2021 and July 2022 were rigorously screened using convenience sampling.
Description
Inclusion Criteria:
- patients whose clinical manifestations met the diagnostic criteria for stroke and whose stroke was confirmed by imaging (cranial computed tomography or cranial magnetic resonance imaging)
- those with first-episode stroke and in a stable condition
- those who were conscious and able to cooperate with the investigation
- those who gave informed consent and volunteered to participate in the study
Exclusion Criteria:
- patients with severe aphasia
- those with severe cognitive impairment who were unable to cooperate with examinations or questionnaires
- those with malignant tumours
- those with degenerative diseases of the central nervous system, such as Parkinson's disease
- those who were unable to cooperate with the doctor in the examination for other reasons
- those with a previous history of mental illness
- those with other recent major stressful life events, such as divorce or death of a loved one
- those with pre-stroke fatigue (PrSF)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
activities of daily living
Time Frame: Before hospitalization
|
modified Barthel index (MBI) is a tool most commonly used to assess the ability of stroke patients to perform activities of daily living.
The measurement consists of 10 items, namely feeding, bed-to-wheelchair transfer, personal hygiene, toileting, bathing, walking, walking up and down stairs, dressing and bowel control, with a total score of 100.
The lower the MBI score is, the more severe the dysfunction and the greater the dependence.
The degree of dependence was categorised into four grades, with ≤40 points categorised as severe dependence (all items required care from others - poor), 41-60 points categorised as moderate dependence (most items required care from others - fair) and 61-90 points and 90-100 points, categorised as mild or no dependence, respectively (few or no items required care from others - good).
|
Before hospitalization
|
|
family adaptation, partnership, growth, affection and resolve (APGAR) score
Time Frame: First day after hospitalization
|
assess patients' satisfaction with family functioning.
It was developed to measure the five dimensions of adaptation, partnership, growth, affection and resolve in five separate questions.
Each question was assigned a score of 0-2, with a total score of 0-10 points.
The degree of family dysfunction was divided based on the total score, with 7-10 points defined as good family function, 4-6 points as moderate family dysfunction and 0-3 points as severe family dysfunction, with a Cronbach's α coefficient of 0.94
|
First day after hospitalization
|
|
Post-stroke fatigue
Time Frame: Day 5 of hospitalization
|
Post-stroke fatigue was scored using the Fatigue Severity Scale, which is mainly designed to assess the severity of physical and mental fatigue felt by patients as a result of the disease.
When assessing stroke patients using the FSS, some scholars have diagnosed a score of ≥36 points as indicative of PSF.
The FSS is comprised of a total of nine entries, each of which is scored on a 7-point Likert scale ranging from 1 to 7. A score of 1 indicates a 'strongly disagree' response to the corresponding entry, and a score of 7 represents a 'strongly agree' response to the corresponding entry.
The final FSS score for the patient was obtained by summing the total score of the nine entries.
The higher the score is, the more severe the patient's fatigue。
|
Day 5 of hospitalization
|
|
Sleep Disturbances
Time Frame: Day 5 of hospitalization
|
The Athens Insomnia Scale (AIS) is used to measure the sleep quality of patients during the study period.
AIS is an internationally recognized self-assessment scale for sleep quality, consisting of 8 items.
The scale is a 4-point Likert scale, scored 0, 1, 2, or 3, with 0 representing "not at all" and 3 representing a "severe" impact.
The total score is 24 points.
Scores ranging from 0-4 indicate no sleep disturbances, 4-6 suggest possible insomnia, and scores above 6 represent insomnia.
The higher the score, the poorer the sleep quality and the more severe the sleep problems.
The Cronbach's alpha coefficient for this scale is 0.875.
|
Day 5 of hospitalization
|
|
Anxiety and Depression
Time Frame: Day 5 of hospitalization
|
The Hospital Anxiety and Depression Scale (HADS) is composed of 14 items divided into two subscales: the depression subscale (7 items) and the anxiety subscale (7 items).
Scores from 0 to 7 indicate no symptoms, 8 to 10 suggest possible symptoms, and 11 to 21 indicate definite symptoms.
The overall Cronbach's alpha coefficient for the scale, as well as those of the anxiety and depression subscales, are 0.88 and 0.81, respectively.
|
Day 5 of hospitalization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 18, 2021
Primary Completion (Actual)
July 20, 2022
Study Completion (Actual)
August 10, 2022
Study Registration Dates
First Submitted
July 31, 2024
First Submitted That Met QC Criteria
July 31, 2024
First Posted (Actual)
August 5, 2024
Study Record Updates
Last Update Posted (Actual)
October 26, 2024
Last Update Submitted That Met QC Criteria
October 23, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Meichun Shu
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.